Articles related to CARDIAC SURGERY

Cardiologist noted patient was “low-risk from cardiac standpoint; however, I am more concerned with her respiratory status than her cardiac status at this point in time” – yet surgery proceeded without addressing this documented concern.

Registry data shows that comorbidities not captured in traditional surgical risk scores, particularly atrial fibrillation and poor baseline functional status, significantly impact post-TAVR outcomes in low-risk patients.

DETECT AS trial showed electronic notifications increased AVR rates by 11% overall and 14% in symptomatic patients, while EARLY TAVR analyses confirmed superior outcomes with timely intervention versus surveillance, with biomarkers failing to predict optimal treatment timing.

The bRIGHT study demonstrates that T-TEER using the TriClip system can lead to sustained TR reduction and quality of life improvements in a diverse, real-world population with advanced tricuspid valve disease.

The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.

Pulmonary thromboendarterectomy (PTE) offers significant symptom improvement for over 75% of CTEPH patients. Specialized care centers are critical for successful outcomes due to the complexity of the procedure.